Limited Coverage Drugs – Budesonide nebules

Generic Name

budesonide 

Strength

0.125 mg/ml, 0.25 mg/ml, 0.25 mg/2ml, 0.5 mg/ml, 0.5 mg/2 ml, 1.0 mg/2 ml  
Form nebule and solution

Special Authority Criteria

Approval Period

1. Person who has cognitive impairment
PLUS
has had an unsuccessful trial in the use of an inhaler attached to an aerochamber with a mouthpiece.

OR

2. Person who is living independently
PLUS
either suffers from severe upper extremity disability or lacks fine motor co-ordination to a degree that precludes effective inhaler techniques, even when aided by inhaler-assistance devices.

OR

3. Resident of a long-term care facility
PLUS
regularly requires the administration of three or more inhaled medications at least three times daily.

OR

4. Person who has difficulty in generating adequate inspiratory effort that he/she is unable to achieve therapeutic benefit from an inhaler with an aerochamber.

Indefinite

 

Practitioner Exemptions

  • No practitioner exemptions

Special Notes

  • Special Authority is not required for individuals 18 years and younger.

Special Authority Request Form(s)